News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Cathy Eng: Apixaban for the primary endpoint of cancer-related recurrent thrombosis
Cathy Eng/X
Apr 14, 2025, 11:48

Cathy Eng: Apixaban for the primary endpoint of cancer-related recurrent thrombosis

Cathy Eng, VICC Associate Director, Strategic Relations and Research Partnerships at Vanderbilt-Ingram Cancer, shared a post on X:

“Important article: Cancer related thrombosis.

2.5 mg PO BID Apixaban = ⁩ 5.0 mg po BID x 12M for primary endpoint of recurrent thrombosis.”

Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism

Authors: Isabelle Mahé et al.

Cathy Eng

New Paper Alert: Reduced-Dose Apixaban Found Effective for Extended Treatment of Cancer-Associated VTE

Adam Torbicki Alexander T. Cohen Anthony Maraveyas apixaban Aristotelis Bamias cancer Cecilia Becattini Céline Chapelle Cihan Ay Claire Grange Didier Mayeur Eric Vicaut Erik Yeo Francis Couturaud Frederikus A. Klok Giancarlo Agnelli Grégoire Le Gal Guy Meyer Helia Robert-Ebadi Isabelle Mahé Jean Chidiac Juan J. López-Núñez Kostas Syrigos Laurent Bertoletti Manuel Monreal Marc Carrier Marc Righini Menno V. Huisman Nicolas Falvo Olivier Sanchez OncoDaily Oncology Patrick Mismetti Peter Verhamme Peter Westerweel Philippe Girard Remedios Otero-Candelera Sebastian Szmit Silvy Laporte
Special Coverage
Positive
Apr 15, 2025, 08:03
Rawan Hammad: Thank you to the speakers, moderators, organizers and attendees who made SIOP Asia Riyadh 2025 a success!
Blog
Apr 15, 2025, 07:52
Basel Refky: Presenting in Lebanon, Masterclass in Cairo, and a Publication — A Tough Weekend but Fruitful
Blog
Apr 15, 2025, 07:52
Luchuo Engelbert Bain: The Future is bright - African medical students taking their future into their hands
Blog
Apr 15, 2025, 07:40
Estela Rodriguez: The second-line options for EGFR lung cancer beyond platinum-chemo after best therapies upfront
Blog
Apr 15, 2025, 07:23
EACR about their affiliated journal, Molecular Oncology
Blog
Apr 15, 2025, 07:21
Enrolling for the ComboMATCH Treatment Trial E5 - ECOG-ACRIN Cancer Research Group
Opinion
Apr 15, 2025, 07:10
The NCCN 2025 Breast Cancer Congress recorded presentations are now available
Blog
Apr 15, 2025, 07:09
Roberto Ferrara: Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC
Blog
Apr 15, 2025, 07:04
Imane Bensalim: Honored to have participated in Sim Africa 2025
Blog
Apr 15, 2025, 06:40
The application for the 2025 Ambassador Program is open - American Society of Hematology
Blog
Apr 15, 2025, 06:16
Applications for the ENYGO Introduction to Robotic Surgery Course close May 12 - ESGO
Blog
Apr 15, 2025, 05:15
Don't miss the NCI Rising Scholars Cancer Research Seminar Series featuring Dr. Juan C. Osorio - Train at NCI